Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

72.44
+2.824.05%
Volume:54.94K
Turnover:3.90M
Market Cap:106.83M
PE:- -
High:72.44
Open:69.94
Low:69.80
Close:69.62
52wk High:72.44
52wk Low:40.17
Shares:1.47M
Float Shares:1.47M
Volume Ratio:1.63
T/O Rate:3.73%
Dividend:0.65
Dividend Rate:0.90%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna CEO's Surprising Comment Gives Clues About Where Drugmaker is Going Next

Dow Jones
·
Sep 24

Moderna rises 4.6%

TIPRANKS
·
Sep 23

Early notable gainers among liquid option names on September 23rd

TIPRANKS
·
Sep 23

Sensorion doubles down on GJB2 gene therapy as SENS-601 enters Phase I/II

TIPRANKS
·
Sep 23

These 'Moonshot' Biotech Stocks Could Break Out, Morgan Stanley Says. What Must Go Right.

Dow Jones
·
Sep 23

Natera Inc Stock (NTRA) Moved Up by 5.67% on Sep 22: Facts Behind the Movement

TradingKey
·
Sep 23

Cboe data suggests bullish flow in Moderna with shares up 5.72%

TIPRANKS
·
Sep 23

New precision medicine venture gives Syngenis added firepower

The West Australian
·
Sep 23

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Sep 23

Moderna up over 7%, on Track for Highest Close Since January 2023

Dow Jones
·
Sep 22

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 22

Forge Nano and Nanexa to Develop Gmp-Compatible Ald Manufacturing Equipment

Reuters
·
Sep 22

Nanexa, Forge Nano Enter Joint Development Deal on GMP-Scale ALD Equipment for PharmaShell Injectables

Reuters
·
Sep 22

Natera’s Signatera Wins Japan PMDA Approval as Companion Diagnostic in Muscle-Invasive Bladder Cancer

Reuters
·
Sep 22

Signatera™ Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer

THOMSON REUTERS
·
Sep 22

Natera- Signatera Commercial Launch in Japan Expected in 1H 2027

THOMSON REUTERS
·
Sep 22

Moderna Inc. Stock Climbs 12.3%, Outperforms Peers

Dow Jones
·
Sep 22

Moderna Provides Details on Data Presentations at Upcoming Conferences

MT Newswires Live
·
Sep 22

Twist Bioscience CEO Emily M. Leproust Disposes of USD 51.47 Million in Common Shares

Reuters
·
Sep 22

Why Is Moderna Stock (MRNA) Soaring Today, September 21?

TIPRANKS
·
Sep 22